Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Endo Health Solutions (ENDP) issues a statement in response to the FDA's decision to deny its...

  • Thursday, August 23, 2012, 7:52 PM ET
    Endo Health Solutions (ENDP) issues a statement in response to the FDA's decision to deny its citizen petition and approve a generic version of Lidoderm, saying it's disappointed with the outcome. The company says approval of a generic version without requiring clinical endpoint studies is inadequate to establish the safety and efficacy of the medication.
Track new comments on this story

This news story has 3 comments:

  •  
    I did read this twice - shouldn't it say adequate in the last sentence? Somehow I do not get this one.
    23 Aug 2012, 07:54 PM Reply Like
  •  
    No, ENDP is trying to stop the release of generic competition to THEIR brand name drug.
    23 Aug 2012, 08:44 PM Reply Like
  •  
    Ah, ok. TY.
    23 Aug 2012, 09:36 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »